Background
Cholesterol-doxorubicin (Chol-DOX) is a prodrug form of the anticancer agent doxorubicin .1 Chol-DOX, when combined with tocopherol polyetlene glycol succinate/tocofersolan in nanoassemblies, reduces MCF-7 and MDA-MB-231 breast cancer cell viability.
动态评分
0.0